Flagship Ventures Fund V, L.P. 13D and 13G filings for Kaleido Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 5:15 pm Purchase |
2021-02-08 | 13D | Kaleido Biosciences, Inc. KLDO |
Flagship Ventures Fund V, L.P. | 19,575,710 47.700% |
215,000 (+1.11%) |
Filing |
| 2020-06-08 4:30 pm Purchase |
2020-06-04 | 13D | Kaleido Biosciences, Inc. KLDO |
Flagship Ventures Fund V, L.P. | 19,360,710 55.000% |
2,000,000 (+11.52%) |
Filing |